Samse SA (EPA:SAMS)

Sage Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	511	494	693	646	710	521
Market Cap Growth	-28.74%	-28.74%	7.15%	-8.94%	36.39%	-10.69%
Enterprise Value	1,010	965	974	960	945	733
Last Close Price	151.00	136.64	181.20	155.68	158.19	111.10
PE Ratio	19.69	18.79	9.06	6.81	7.59	10.99
Forward PE	17.40	20.60	9.95	7.52	10.07	12.24
PS Ratio	0.26	0.26	0.37	0.34	0.40	0.34
PB Ratio	0.83	0.80	1.08	1.04	1.22	1.04
P/TBV Ratio	0.96	0.92	1.20	1.14	1.35	1.17
P/FCF Ratio	6.86	6.62	7.44	8.08	10.68	4.75
P/OCF Ratio	3.89	3.75	4.68	5.19	7.12	3.67
PEG Ratio	1.10	1.89	1.89	1.89	1.89	2.19
EV/Sales Ratio	0.52	0.50	0.52	0.50	0.53	0.49
EV/EBITDA Ratio	7.91	10.31	5.90	5.33	5.33	5.88
EV/EBIT Ratio	18.39	17.66	9.15	7.60	7.56	10.08
EV/FCF Ratio	13.54	12.94	10.46	12.00	14.21	6.69
Debt / Equity Ratio	1.00	1.00	0.63	0.60	0.60	0.73
Debt / EBITDA Ratio	4.84	4.84	2.45	2.06	1.98	2.92
Debt / FCF Ratio	8.27	8.27	4.35	4.64	5.28	3.32
Asset Turnover	1.22	1.22	1.29	1.35	1.35	1.24
Inventory Turnover	3.92	3.92	3.68	3.63	3.87	3.81
Quick Ratio	0.94	0.94	1.08	0.99	0.93	0.97
Current Ratio	1.60	1.60	1.77	1.73	1.64	1.62
Return on Equity (ROE)	4.45%	4.45%	12.56%	16.27%	17.83%	9.80%
Return on Assets (ROA)	2.16%	2.16%	4.54%	5.58%	5.95%	3.72%
Return on Capital (ROIC)	3.00%	3.00%	6.53%	8.21%	8.69%	5.30%
Return on Capital Employed (ROCE)	4.80%	4.80%	10.80%	13.50%	14.20%	8.90%
Earnings Yield	5.14%	5.32%	11.03%	14.68%	13.17%	9.10%
FCF Yield	14.59%	15.12%	13.45%	12.37%	9.37%	21.07%
Dividend Yield	5.30%	5.85%	5.52%	10.28%	10.11%	7.20%
Payout Ratio	132.08%	132.08%	72.38%	58.28%	29.59%	116.86%
Buyback Yield / Dilution	0.11%	0.11%	0.38%	0.17%	0.03%	0.04%
Total Shareholder Return	5.46%	5.97%	5.90%	10.44%	10.14%	7.24%

Updated Sep 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.